Jie Min Luo
Director Ejecutivo en AMOY DIAGNOSTICS CO., LTD. .
Cargos activos de Jie Min Luo
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| AMOY DIAGNOSTICS CO., LTD. | Director/Miembro de la Junta | 13/08/2021 | - |
| Director Ejecutivo | 01/12/2021 | - | |
| Contacto de Relaciones con Inversores | 18/06/2015 | - | |
| Secretario Corporativo | 18/06/2015 | 01/12/2021 | |
SinoPath Medical Investment (Beijing) Co., Ltd.
 SinoPath Medical Investment (Beijing) Co., Ltd. Medical/Nursing ServicesHealth Services SinoPath Medical Investment (Beijing) Co., Ltd. engages in the third-party medical diagnostic genetics laboratory. It provides clinical genetic testing, consultation, and advisory services. Its products include cancer detection, remote pathology consultation, hereditary cancer detection, hereditary cardiovascular disease testing, single-gene genetic disease detection, susceptibility gene examination, and immunohistochemistry. The company was founded on June 30, 2013 and is headquartered in Beijing, China. | Director/Miembro de la Junta | - | - |
Historial de carrera de Jie Min Luo
Estadísticas
Internacional
| China | 3 |
Operativa
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| Investor Relations Contact | 1 |
Sectorial
| Health Services | 2 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| AMOY DIAGNOSTICS CO., LTD. | Health Technology |
| Empresas privadas | 1 |
|---|---|
SinoPath Medical Investment (Beijing) Co., Ltd.
SinoPath Medical Investment (Beijing) Co., Ltd. Medical/Nursing ServicesHealth Services SinoPath Medical Investment (Beijing) Co., Ltd. engages in the third-party medical diagnostic genetics laboratory. It provides clinical genetic testing, consultation, and advisory services. Its products include cancer detection, remote pathology consultation, hereditary cancer detection, hereditary cardiovascular disease testing, single-gene genetic disease detection, susceptibility gene examination, and immunohistochemistry. The company was founded on June 30, 2013 and is headquartered in Beijing, China. | Health Services |
- Bolsa de valores
- Insiders
- Jie Min Luo
- Experiencia
